share_log

S-1: General form for registration of securities under the Securities Act of 1933

S-1: General form for registration of securities under the Securities Act of 1933

S-1：證券上市註冊聲明
美股SEC公告 ·  2024/10/26 05:08

Moomoo AI 已提取核心訊息

Aclarion, Inc. has entered into an active Equity Line Purchase Agreement with White Lion Capital LLC, effective since October 9, 2023. Under this agreement, Aclarion has the potential to sell up to $10 million in common stock shares until December 31, 2024. As of August 2024, Aclarion has already sold approximately $3.216 million worth of shares to White Lion. Additionally, White Lion received Commitment Shares valued at $75,000. The agreement allows Aclarion to direct White Lion to purchase shares at prices that vary with the market. Aclarion may terminate the agreement under specific conditions and has registered additional shares for potential future sales to White Lion. The proceeds from these sales are earmarked for general corporate purposes, including working capital. This funding is crucial for Aclarion's ongoing operations and its ability to continue as a going concern, with the aim to sustain liquidity and fund operations into the third quarter of 2024.
Aclarion, Inc. has entered into an active Equity Line Purchase Agreement with White Lion Capital LLC, effective since October 9, 2023. Under this agreement, Aclarion has the potential to sell up to $10 million in common stock shares until December 31, 2024. As of August 2024, Aclarion has already sold approximately $3.216 million worth of shares to White Lion. Additionally, White Lion received Commitment Shares valued at $75,000. The agreement allows Aclarion to direct White Lion to purchase shares at prices that vary with the market. Aclarion may terminate the agreement under specific conditions and has registered additional shares for potential future sales to White Lion. The proceeds from these sales are earmarked for general corporate purposes, including working capital. This funding is crucial for Aclarion's ongoing operations and its ability to continue as a going concern, with the aim to sustain liquidity and fund operations into the third quarter of 2024.
Aclarion，Inc.已於2023年10月9日與White Lion Capital LLC簽署了一份有力的股權認購協議。根據該協議，Aclarion有可能在2024年12月31日前最多賣出1000萬美元的普通股股票。截至2024年8月，Aclarion已向White Lion賣出了約321.6萬美元的股票。此外，White Lion還收到了價值75000美元的承諾股票。該協議允許Aclarion指示White Lion按市場變動的價格購買股票。Aclarion可以在特定條件下終止協議，並已註冊了額外的股份，用於潛在的未來銷售給White Lion。這些銷售所得款項用於一般企業用途，包括營運資金。這種融資對Aclarion的持續運營至關重要，有利於確保流動性及爲2024年第三季度的營運提供資金支持。
Aclarion，Inc.已於2023年10月9日與White Lion Capital LLC簽署了一份有力的股權認購協議。根據該協議，Aclarion有可能在2024年12月31日前最多賣出1000萬美元的普通股股票。截至2024年8月，Aclarion已向White Lion賣出了約321.6萬美元的股票。此外，White Lion還收到了價值75000美元的承諾股票。該協議允許Aclarion指示White Lion按市場變動的價格購買股票。Aclarion可以在特定條件下終止協議，並已註冊了額外的股份，用於潛在的未來銷售給White Lion。這些銷售所得款項用於一般企業用途，包括營運資金。這種融資對Aclarion的持續運營至關重要，有利於確保流動性及爲2024年第三季度的營運提供資金支持。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

獨立文件5  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    iCoreConnect
    ICCT
    -- 1.250
    SHL Telemedicine
    SHLT
    -- 2.270
    VSee Health
    VSEE
    -- 1.177
    Definitive Healthcare
    DH
    -- 2.985
    EUDA Health
    EUDA
    -- 3.700
    解鎖完整榜單
    重估中國資產
    繼中國開創性的DeepSeek技術推出之後，華爾街大行重估對中國市場的投資前景。
    熱門討論
    FOMC維持利率但不確定性高企：美股後市走向如何？
    🎙️討論 1. 美聯儲強調政策路徑存在「高度不確定性」，你更關注利率預期變化還是經濟數據對市場的短期影響？ 2. 若核心通脹維持高位，哪類板塊更具交易機會——防禦型股票還是科技成長股？ 展开
    聯邦公開市場委員會新聞發佈會，2025年3月19日